Sangamo Therapeutics
SGMO
#8058
Rank
โ‚ฌ0.21 B
Marketcap
1,02ย โ‚ฌ
Share price
-4.46%
Change (1 day)
-11.08%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2024 (TTM): -โ‚ฌ0.13 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are โ‚ฌ52.29 Million. In 2023 the company made an earning of -โ‚ฌ0.12 Billion, an increase over its 2022 earnings that were of -โ‚ฌ0.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚ฌ0.13 Billion9.02%
2023 -โ‚ฌ0.12 Billion-40.88%
2022 -โ‚ฌ0.2 Billion9.79%
2021 -โ‚ฌ0.18 Billion41.52%
2020 -โ‚ฌ0.13 Billion23.17%
2019 -โ‚ฌ0.11 Billion36.33%
2018 -โ‚ฌ73.48 Million36.89%
2017 -โ‚ฌ53.68 Million-22.32%
2016 -โ‚ฌ69.11 Million54.86%
2015 -โ‚ฌ44.63 Million75.62%
2014 -โ‚ฌ25.41 Million0.13%
2013 -โ‚ฌ25.38 Million
2011 -โ‚ฌ34.12 Million43.66%
2010 -โ‚ฌ23.75 Million28.52%
2009 -โ‚ฌ18.48 Million-23.55%
2008 -โ‚ฌ24.17 Million2.45%
2007 -โ‚ฌ23.6 Million19.5%
2006 -โ‚ฌ19.75 Million50.78%
2005 -โ‚ฌ13.1 Million75%
2004 -โ‚ฌ7.49 Million-33.25%
2003 -โ‚ฌ11.21 Million-62.27%
2002 -โ‚ฌ29.71 Million102.82%
2001 -โ‚ฌ14.65 Million23.21%
2000 -โ‚ฌ11.89 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚ฌ0.16 B-231.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.23 Billion 75.47%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ4.45 B-3,586.04%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.81 B-1,520.05%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.52 B-1,292.06%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ16.61 B-13,094.99%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.37 B-391.65%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ14.25 B-11,255.48%๐Ÿ‡บ๐Ÿ‡ธ USA